ALX Oncology Holdings Inc.
ALXO
$2.19
$0.041.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.60% | -6.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.17% | -4.01% | |||
| Operating Income | -2.17% | 4.01% | |||
| Income Before Tax | -3.18% | 14.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.18% | 14.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.18% | 14.66% | |||
| EBIT | -2.17% | 4.01% | |||
| EBITDA | -2.19% | 3.88% | |||
| EPS Basic | -1.84% | 14.87% | |||
| Normalized Basic EPS | -1.86% | 3.00% | |||
| EPS Diluted | -1.84% | 14.87% | |||
| Normalized Diluted EPS | -1.86% | 3.00% | |||
| Average Basic Shares Outstanding | 1.32% | 0.25% | |||
| Average Diluted Shares Outstanding | 1.32% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||